In vivo monoamine oxidase inhibition by d-amphetamine

Miller, Harold H.; Shore, Parkhurst A.; Clarke, David E.

doi:10.1016/0006-2952(80)90429-3

Cited by 120Neurotransmitter Receptor Influence on BehaviorParkinson's Disease Mechanisms and TreatmentsNeuroscience and Neuropharmacology Research

In vivo monoamine oxidase inhibition by d-amphetamine

Miller, Harold H., Shore, Parkhurst A., Clarke, David E.·1980·Biochemical Pharmacology

DOI 10.1016/0006-2952(80)90429-3

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1016/0006-2952(80)90429-3

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Amphetamine inhibits monoamine oxidase activity, decreasing cytosolic monoamine breakdown.
“Furthermore, AMP inhibits monoamine oxidase (MAO) activity (79, 90), which decreases cytosolic monoamine breakdown.”
From The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities (2018) · cites this paper as [79]

Some observations upon a new inhibitor of monoamine oxidase in brain tissue
Johnston, J. P. (1968) · Biochemical Pharmacology · doi:10.1016/0006-2952(68)90066-x · Cited by 1,597 · see citing works
Studies on the distinction between uptake inhibition and release of [3H]dopamine in rat brain tissue slices
Heikkila, R. E., Orlansky, H., & Cohen, G. (1975) · Biochemical Pharmacology · doi:10.1016/0006-2952(75)90152-5 · Cited by 468 · see citing works
Central dopaminergic neurons: Effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid
Roth, R. H., Murrin, L. C., & Walters, J. R. (1976) · European Journal of Pharmacology · doi:10.1016/0014-2999(76)90268-5 · Cited by 364 · see citing works
Another look at the monoamine oxidases and the monoamine oxidase inhibitor drugs
Neff, N. H., & Yang, H. (1974) · Life Sciences · doi:10.1016/0024-3205(74)90089-7 · Cited by 333 · see citing works
A COMPARISON OF THE CAPACITIES OF ISOMERS OF AMPHETAMINE, DEOXYPIPRADROL AND METHYLPHENIDATE TO INHIBIT THE UPTAKE OF TRITIATED CATECHOLAMINES INTO RAT CEREBRAL CORTEX SLICES, SYNAPTOSOMAL PREPARATIONS OF RAT CEREBRAL CORTEX, HYPOTHALAMUS AND STRIATUM AND INTO ADRENERGIC NERVES OF RABBIT AORTA
Ferris, R. M., Tang, F. L. M., & Maxwell, R. A. (1972) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29222-9 · Cited by 303 · see citing works
Monoamine Oxidase and its Inhibition.
(1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-86-1-123_1 · Cited by 263 · see citing works
Regional rat brain levels of 3,4-dihydroxyphenylacetic acid and homovanillic acid: concurrent fluorometric measurement and influence of drugs
Westerink, B. H. C., & Korf, J. (1976) · European Journal of Pharmacology · doi:10.1016/0014-2999(76)90331-9 · Cited by 240 · see citing works
Substrate- and inhibitor-related characteristics of human platelet monoamine oxidase
Donnelly, C. H., & Murphy, D. L. (1977) · Biochemical Pharmacology · doi:10.1016/0006-2952(77)90398-7 · Cited by 238 · see citing works
Millennium Cohort Study: Age 17, Sweep 7, 2018
University of London, I. O. E. (2021) · VocBench (University of Rome Tor Vergata) · doi:10.5255/ukda-sn-8682-2 · Cited by 206 · see citing works
The effect of tropolone on the formation of 3,4‐dihydroxyphenylacetic acid and 4‐hydroxy‐3‐methoxyphenylacetic acid in the brain of the mouse
Murphy, G. F., Robinson, D. S., & Sharman, D. F. (1969) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1969.tb08308.x · Cited by 198 · see citing works
Inhibition of monoamine oxidase by amphetamine and related compounds
Mantle, T. J., Tipton, K. F., & Garrett, N. (1976) · Biochemical Pharmacology · doi:10.1016/0006-2952(76)90432-9 · Cited by 191 · see citing works
Effects of amphetamine on the turnover rate of brain catecholamines and motor activity
Costa, E., Groppetti, A., & Naimzada, M. K. (1972) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1972.tb07312.x · Cited by 177 · see citing works
Biochemical differentiation of amphetaminevsmethylphenidate and nomifensine in rats
Bræstrup, C. (1977) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1977.tb11370.x · Cited by 145 · see citing works
Preferential deamination of dopamine by an A type monoamine oxidase in rat brain
Waldmeier, P. C., Delini‐Stula, A., & Ma�tre, L. (1976) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00506483 · Cited by 142 · see citing works
Importance of nervous impulse flow for the neuroleptic induced increase in amine turnover in central dopamine neurons
Andén, N. ‐., CORRODI, H., Fuxé, K., & Ungerstedt, U. (1971) · European Journal of Pharmacology · doi:10.1016/0014-2999(71)90173-7 · Cited by 142 · see citing works
The influence of monoamine oxidase inhibition on catecholamine synthesis
Neff, N. H., & Costa, E. (1966) · Life Sciences · doi:10.1016/0024-3205(66)90204-9 · Cited by 139 · see citing works
The monoamine oxidase B inhibitor deprenyl potentiates phenylethylamine behaviour in rats without inhibition of catecholamine metabolite formation
Bræstrup, C., Andersen, H., & Randrup, A. A. (1975) · European Journal of Pharmacology · doi:10.1016/0014-2999(75)90238-1 · Cited by 126 · see citing works
Actions of amfonelic acid and other non-amphetamine stimulants on the dopamine neuron
Shore, P. A. (1976) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1976.tb04078.x · Cited by 125 · see citing works
Self-citation
MULTIPLE BINDING SITES OF HUMAN BRAIN AND LIVER MONOAMINE OXIDASE: SUBSTRATE SPECIFICITIES, SELECTIVE INHIBITIONS, AND ATTEMPTS TO SEPARATE ENZYME FORMS
White, H. L., & Glassman, A. T. (1977) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1977.tb06502.x · Cited by 106 · see citing works
THE UPTAKE AND STORAGE OF H3-NOREPINEPHRINE IN THE RESERPINE-PRETREATED RAT HEART
Iversen, L. L., Glowinski, J., & Axelrod, J. (1965) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)27167-1 · Cited by 104 · see citing works
Benzedrine (β-phenylisopropylamine) and brain metabolism
Mann, P. J., & Quastel, J. H. (1940) · Biochemical Journal · doi:10.1042/bj0340414 · Cited by 94 · see citing works
Long-Term Amphetamine Treatment Decreases Brain Serotonin Metabolism: Implications for Theories of Schizophrenia
Trulson, M. E., & Jacobs, B. L. (1979) · Science · doi:10.1126/science.572992 · Cited by 90 · see citing works
Subcellular localization of types A and B monoamine oxidase in rat brain
Student, A. K., & Edwards, D. J. (1977) · Biochemical Pharmacology · doi:10.1016/0006-2952(77)90437-3 · Cited by 89 · see citing works
CHARACTERISTICS OF AMPHETAMINE-INDUCED RELEASE OF NOREPINEPHRINE FROM RAT CEREBRAL CORTEX IN VITRO
Ziance, R. J., Azzaro, A. J., & Rutledge, C. O. (1972) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29275-8 · Cited by 74 · see citing works
Inhibition of mouse brain monoamine oxidase by (+)-amphetaminein vivo
Green, A. L., & Hait, M. A. S. E. (1978) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1978.tb13223.x · Cited by 64 · see citing works
Substrate specificity of the different forms of monoamine oxidase in rat liver mitochondria
Ekstedt, B. (1976) · Biochemical Pharmacology · doi:10.1016/0006-2952(76)90359-2 · Cited by 63 · see citing works
Dihydroxyphenylacetic acid conjugate: Natural occurrence and demonstration of probenecid-induced accumulation in rat striatum olfactory tubercles and frontal cortex
Elchisak, M. A., Maas, J. W., & Roth, R. H. (1977) · European Journal of Pharmacology · doi:10.1016/0014-2999(77)90257-6 · Cited by 46 · see citing works
Effects of Benzoquinolizines and Ring-Substituted Aralkylamines on Serotonin Metabolism
Pletscher, A., DAPRADA, M., Burkard, W. P., & Tranzer, J. P. (1968) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60295-1 · Cited by 28 · see citing works
Rat and human cardiac monoamine oxidase: A comparison with other tissues
Dial, E. J., & Clarke, D. E. (1979) · European Journal of Pharmacology · doi:10.1016/0014-2999(79)90480-1 · Cited by 20 · see citing works
Self-citation
Behavioral and biochemical interaction between AMT and (+)-Amphetamine: Relevance to the identification of the functional pool of brain catecholamines
Papeschi, R. (1975) · Psychopharmacology · doi:10.1007/bf00426205 · Cited by 20 · see citing works
Phenylethylamine—Deamination by multiple types of monoamine oxidase
Dial, E. J., & Clarke, D. E. (1978) · Biochemical Pharmacology · doi:10.1016/0006-2952(78)90148-x · Cited by 18 · see citing works
Self-citation
Inability of methylphenidate or mazindol to prevent the lowering of 3,4-dihydroxyphenylacetic acid in rat brain by amphetamine
Fuller, R. W., & Snoddy, H. D. (1979) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1979.tb13468.x · Cited by 16 · see citing works

Flagged first, then by citations

Sorted by citations

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method
Breier, A., Su, T.-P., Saunders, R., Carson, R. E., Kolachana, B. S., de Bartolomeis, A., Weinberger, D. R., Weisenfeld, N., Malhotra, A. K., Eckelman, W. C., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2569 · Cited by 1,154 · see citing works
The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities
Faraone, S. V. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.02.001 · Cited by 631 · see citing works
“…receptor agonist to induce calcium increases and NE release in bovine adrenal chromaffin cells May et al. (1988) • AMP stimulated DA release in the caudate nucleus of rats, as measured by in vivo fast-scan cyclic voltammetry Miller et al. (1980) • AMP inhibited MAO type A activity Mukherjee…”
Mechanisms of Amphetamine Action Revealed in Mice Lacking the Dopamine Transporter
Jones, S. R., Gainetdinov, R. R., Wightman, R. M., & Caron, M. G. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-06-01979.1998 · Cited by 626 · see citing works
“This is consistent with AMPH entering nerve terminals and inhibiting monoamine oxidase (MAO), one of the known actions of AMPH (Green and El Haut, 1978; Miller et al., 1980).”
Background
Amphetamine, past and present – a pharmacological and clinical perspective
Heal, D. J., Smith, S. L., Gosden, J., & Nutt, D. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113482532 · Cited by 622 · see citing works
“Amphetamine’s isomers have long been known to be inhibitors of this important catabolising enzyme (Mantle et al., 1976; Miller et al., 1980; Robinson, 1985).”
Background
In Vivo Measurement of Dopamine and Its Metabolites by Intracerebral Dialysis: Changes After d‐Amphetamine
Zetterström, T., Sharp, T., Marsden, C. A., & Ungerstedt, U. (1983) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1983.tb00893.x · Cited by 616 · see citing works
Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man
Gerlach, M., & Riederer, P. F. (1996) · Journal of Neural Transmission · doi:10.1007/bf01291788 · Cited by 496 · see citing works
“Since amphetamines on the one hand liberate dopamine in large amounts in a nonphysiological fashion, and on the other hand also inhibit its enzymatic breakdown by inhibition of MAO (Miller et al., 1980), "oxidative stress" such as that which occurs following 6-OHDA - may be considered a possible causative factor in th…”
Background
Mapping Human Brain Monoamine Oxidase A and B with11C-Labeled Suicide Inactivators and PET
Fowler, J. S., MacGregor, R. R., Wolf, A. P., Arnett, C. D., Dewey, S. L., Schlyer, D. J., Christman, D. R., Logan, J., Smith, M. R., Sachs, H., et al. (1987) · Science · doi:10.1126/science.3099392 · Cited by 389 · see citing works
Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine
Kuczenski, R., Segal, D., Cho, A., & Melega, W. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-02-01308.1995 · Cited by 376 · see citing works
“It is unlikely that the decline in metabolites reflects AMPH inhibition of monoamine oxidase, since most evidence suggests that such an effect occurs only at relatively high AMPH concentrations (Green and El Hait, 1980; Miller et al., 1980).”
Background
In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain
Schmidt, C. J., Levin, J. A., & Lovenberg, W. M. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90729-5 · Cited by 297 · see citing works
Amphetamine‐Induced Dopamine Release in the Rat Striatum: An In Vivo Microdialysis Study
Butcher, S. P., Fairbrother, I. S., Kelly, J. S., & Arbuthnott, G. W. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb02919.x · Cited by 289 · see citing works
Rapid Communication: Attenuation of Methamphetamine‐Induced Neurotoxicity in Copper/Zinc Superoxide Dismutase Transgenic Mice
Cadet, J. L., Sheng, P., All, S., Rothman, R. B., Carlson, E. J., & Epstein, C. J. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62010380.x · Cited by 263 · see citing works
A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse
Dwoskin, L. P., & Crooks, P. A. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00899-1 · Cited by 219 · see citing works
The neuropharmacology of ADHD drugs in vivo: Insights on efficacy and safety
Heal, D. J., Cheetham, S. C., & Smith, S. L. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.08.020 · Cited by 198 · see citing works
“Surprisingly, it is not known whether D- or DL-MPH are inhibitors of MAO.”
The functional role of monoamine oxidases A and B in the mammalian central nervous system
Berry, M. D., Juorio, A. V., & Paterson, I. A. (1994) · Progress in Neurobiology · doi:10.1016/0301-0082(94)90081-7 · Cited by 181 · see citing works
Drug- and behavior-associated changes in dopamine-related electrochemical signals during intravenous cocaine self-administration in rats
Gratton, A. P., & Wise, R. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-07-04130.1994 · Cited by 169 · see citing works
“Increases in voltammetric signals have been recorded in both the feeding (Mitchell and Gratton, 1992) and copulation paradigms (Phillips et al., I99 1). Kalivas and Duffy (1990) found microdialysis evidence of increased NAcc DA when rats with a history of cocaine injections were given saline injections and placed in t…”
Background
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148 · see citing works
“The ability of AMPH to block MAO has been repeatedly demonstrated both in vitro and in vivo (Mantle et al., 1976; Green and el Hait, 1978; Clarke et al., 1979; Miller et al., 1980; Robinson, 1985).”
Background
Intracellular Patch Electrochemistry: Regulation of Cytosolic Catecholamines in Chromaffin Cells
Mosharov, E. V., Gong, L., Khanna, B., Sulzer, D. L., & Lindau, M. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05835.2003 · Cited by 145 · see citing works
“The actions of amphetamines include inhibition of mitochondrial monoamine oxidase ( MAO ) ( Davidson et al .”
Influential
Neuroadaptations in the dopaminergic system after active self-administration but not after passive administration of methamphetamine
Stefański, R., Ladenheim, B., Lee, S. H., Cadet, J. L., & Goldberg, S. R. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00094-1 · Cited by 139 · see citing works
Lobeline and Nicotine Evoke [3H]Overflow from Rat Striatal Slices Preloaded with [3H]Dopamine: Differential Inhibition of Synaptosomal and Vesicular [3H]Dopamine Uptake
Teng, L., Crooks, P. A., Sonsalla, P. K., & Dwoskin, L. P. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36537-1 · Cited by 133 · see citing works
Further evaluation of the mechanism by which amphetamine reduces striatal dopamine metabolism: a brain dialysis study
Zetterström, T., Sharp, T., & Ungerstedt, U. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90002-6 · Cited by 130 · see citing works
Kinetics, mechanism, and inhibition of monoamine oxidase
Ramsay, R. R., & Albreht, A. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1861-9 · Cited by 108 · see citing works
“1976; Dorris 1982) or other drugs (McCoubrey 1957; Yang and Neff 1974) before moving to in vivo pharmacology (Youdim et al. 1971; Miller et al. 1980; Riederer and Jellinger 1983; Da Prada et al. 1990).”
Background
A review of the pharmacology of selegiline
Heinonen, E. H., & Lammintausta, R. A. S. (1991) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1991.tb05020.x · Cited by 103 · see citing works
Behavioral effects of bidirectional modulators of brain monoamines reserpine and d-amphetamine in zebrafish
Kyzar, E. J., Stewart, A., Landsman, S., Collins, C. J., Gebhardt, M. J., Robinson, K. S. L., & Kalueff, A. V. (2013) · Brain Research · doi:10.1016/j.brainres.2013.06.033 · Cited by 88 · see citing works
The reverse transport of DA, what physiological significance?
Leviel, V. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(00)00076-0 · Cited by 87 · see citing works
Lobeline Inhibits the Neurochemical and Behavioral Effects of Amphetamine
Miller, D. K., Crooks, P. A., Teng, L., Witkin, J. M., Munzar, P., Goldberg, S. R., Acri, J. B., & Dwoskin, L. P. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38847-0 · Cited by 86 · see citing works
Long-term social isolation and medial prefrontal cortex: dopaminergic and cholinergic neurotransmission
Leng, A., Feldon, J., & Ferger, B. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.11.011 · Cited by 83 · see citing works
The neurotoxicity of amphetamines during the adolescent period
Gomes, A., Costa, V. M., Feio‐Azevedo, R., Bastos, M. D. L., Carvalho, F. D., & Capela, J. P. (2014) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2014.12.001 · Cited by 78 · see citing works
Changes in striatal D2-receptor density following chronic treatment with amphetamine as assessed with pet in nonhuman primates
Ginovart, N., Farde, L., Halldin, C., & Swahn, C.-G. (1999) · Synapse · doi:10.1002/(sici)1098-2396(199902)31:2 · Cited by 76 · see citing works
A comparison of cardiac and vascular clorgyline-resistant amine oxidase and monoamine oxidase
Clarke, D. E., Lyles, G. A., & Callingham, B. A. (1982) · Biochemical Pharmacology · doi:10.1016/0006-2952(82)90231-3 · Cited by 77 · see citing works
Self-citation
Neuropharmacology of drugs affecting food intake
Sugrue, M. F. (1987) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(87)90057-x · Cited by 72 · see citing works
Further studies on the long-term depletion of striatal dopamine in iprindole-treated rats by amphetamine
Fuller, R. W., & Hemrick-Luecke, S. K. (1982) · Neuropharmacology · doi:10.1016/0028-3908(82)90027-2 · Cited by 69 · see citing works
Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice
Patel, J. C., Mooslehner, K. A., Chan, P. M., Emson, P. C., & Stamford, J. A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01732.x · Cited by 65 · see citing works
Monoamine oxidase inhibitor antidepressants
Youdim, M. B. H., & Finberg, J. P. M. (1985) · Elsevier eBooks · doi:10.1016/b978-0-444-90350-1.50008-8 · Cited by 63 · see citing works
3-methoxytyramine: Its suitability as an indicator of synaptic dopamine release
Waldmeier, P. C., Lauber, J., Blum, W., & Richter, W. J. (1981) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00499838 · Cited by 62 · see citing works
“There is now convincing evidence that damphetamine preferentially inhibits intraneuronal MAO A in dopaminergic and probably also in other monoaminergic neurons (Braestrup 1977; Green and E1 Hait 1978; Parkinson and Callingham 1979; Miller et al 1980; for a discussion of the evidence see Clarke 1980), in addition to it…”
Background
Interactions of HIV and methamphetamine: Cellular and molecular mechanisms of toxicity potentiation
Cadet, J. L., & Krasnova, I. N. (2007) · Neurotoxicity Research · doi:10.1007/bf03033915 · Cited by 59 · see citing works
Effects of inhibitors of 5-hydroxytryptamine uptake on plasma glucose and their interaction with 5-hydroxytryptophan in producing hypoglycaemia in mice
Wilson, G. A., & Furman, B. L. (1982) · European Journal of Pharmacology · doi:10.1016/0014-2999(82)90027-9 · Cited by 53 · see citing works
Lack of pre-synaptic dopaminergic involvement in modafinil activity in anaesthetized mice: In vivo voltammetry studies
de Séréville, J.-E., Boer, C., Rambert, F. A., & Duteil, J. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90115-5 · Cited by 49 · see citing works
Essential Role of NMDA Receptor Channel ε4 Subunit (GluN2D) in the Effects of Phencyclidine, but Not Methamphetamine
Hagino, Y., Kasai, S., Han, W., Yamamoto, H., Nabeshima, T., Mishina, M., & Ikeda, K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013722 · Cited by 48 · see citing works
“inhibition of monoamine oxidase (MAO) activity [22–24].”
Influence of a carrier transport process on in vivo release and metabolism of dopamine: Dependence of extracellular Na+
Hurd, Y. L., & Ungerstedt, U. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90137-9 · Cited by 46 · see citing works
The acute effects of methamphetamine, amphetamine and p-chloroamphetamine on the cortical serotonergic system of the rat brain: Evidence for differences in the effects of methamphetamine and amphetamine
Peat, M. A., Warren, P. F., Bakhit, C., & Gibb, J. W. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90179-7 · Cited by 43 · see citing works
Nitrous Oxide and Xenon Prevent Amphetamine-Induced Carrier-Mediated Dopamine Release in a Memantine-Like Fashion and Protect Against Behavioral Sensitization
David, H., Ansseau, M., Lemaire, M., & Abraini, J. H. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.007 · Cited by 40 · see citing works
Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: Time course and time-dependent interactions with amfonelic acid
Steranka, L. R. (1982) · Brain Research · doi:10.1016/0006-8993(82)90477-2 · Cited by 39 · see citing works
Cocaine and amphetamine elicit differential effects in rats with a unilateral injection of dopamine transporter antisense oligodeoxynucleotides
Silvia, C. P., Jaber, M., King, G. R., Ellinwood, E. H., & Caron, M. G. (1996) · Neuroscience · doi:10.1016/s0306-4522(96)00399-5 · Cited by 37 · see citing works
Inhibition of methamphetamine-induced hyperlocomotion in mice by clorgyline, a monoamine oxidase-a inhibitor, through alteration of the 5-hydroxytriptamine turnover in the striatum
Kitanaka, N., Kitanaka, J., & Takemura, M. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.09.026 · Cited by 36 · see citing works
Characterization of monoamine release in the lateral hypothalamus of awake, freely moving rats using in vivo microdialysis
Matos, F. F., Rollema, H., & Basbaum, A. I. (1990) · Brain Research · doi:10.1016/0006-8993(90)90192-e · Cited by 36 · see citing works
Serotonin neurotoxicity in rats after combined treatment with a dopaminergic agent followed by a nonneurotoxic 3,4-methylenedioxymethamphetamine (MDMA) analogue
Johnson, M. P., Xuemei, H., & Nichols, D. E. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90106-c · Cited by 35 · see citing works
Activation of Protein Kinase C (PKC) by 3,4-Methylenedioxymethamphetamine (MDMA) Occurs Through the Stimulation of Serotonin Receptors and Transporter
Kramer, H. K. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00026-2 · Cited by 35 · see citing works
“Cocaine is a highly selective DA and NE uptake inhibitor but is a relatively weak 5-HT releaser in a synaptosomal preparations (EC50 10.0 mmol/L) (Miller et al. 1980; Hyde and Bennett 1994; Kramer and Azmitia 1994).”
BackgroundInfluential
CNS-targeting pharmacological interventions for the metabolic syndrome
Stemmer, K., Müller, T. D., DiMarchi, R. D., Pfluger, P. T., & Tschöp, M. H. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129195 · Cited by 32 · see citing works
In vivo analysis of the role of dopamine in stimulant and opiate self-administration.
Gratton, A. P. (1996) · PubMed Central · Cited by 33 · see citing works
Effects of amphetamine and amfonelic acid on the disposition of striatal newly synthesized dopamine
Miller, H. H., & Shore, P. A. (1982) · European Journal of Pharmacology · doi:10.1016/0014-2999(82)90369-7 · Cited by 32 · see citing works
Self-citation
Preclinical pharmacology of amphetamine: Implications for the treatment of neuropsychiatric disorders
Hutson, P. H., Tarazi, F. I., Madhoo, M., Slawecki, C., & Patkar, A. A. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.03.005 · Cited by 31 · see citing works
“, 1987; Ritz & Kuhar, 1989) and weak inhibition of MAO-A (Miller et al., 1980; Karoum et al., 1994).”
Background
Characteristics and specificity of phenelzine and benserazide as inhibitors of benzylamine oxidase and monoamine oxidase
Andree, T. H., & Clarke, D. E. (1982) · Biochemical Pharmacology · doi:10.1016/0006-2952(82)90469-5 · Cited by 30 · see citing works
Self-citation
Differential action of (+)‐amphetamine on electrically evoked dopamine overflow in rat brain slices containing corpus striatum and nucleus accumbens
Wieczorek, W. J., & Kruk, Z. L. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb14813.x · Cited by 28 · see citing works
Amphetamine augments action potential‐dependent dopaminergic signaling in the striatumin vivo
Ramsson, E. S., Covey, D. P., Daberkow, D. P., Litherland, M. T., Juliano, S. A., & Garris, P. A. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07258.x · Cited by 26 · see citing works
“Early studies demonstrated DA synthesis activation (Kuczenski 1975), monoamine oxidase inhibition (Miller et al. 1980), competitive blockade of DA uptake (Krueger 1990), depletion of vesicular DA stores (Floor and Meng 1996), and”
Background
Dopamine turnover estimated by simultaneous LCEC assay of dopamine and dopamine metabolites
Cheng, C., & Wooten, G. F. (1982) · Journal of Pharmacological Methods · doi:10.1016/0160-5402(82)90066-3 · Cited by 25 · see citing works
The late stage following continuous amphetamine administration to rats is correlated with altered dopamine but not serotonin metabolism
Ellison, G. D., & Ratan, R. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90703-2 · Cited by 24 · see citing works
Effect of enantiomers of deprenyl (selegiline) and amphetamine on physical abuse liability and cortical electrical activity in rats
Nickel, B., Schulze, G., & Szelenyi, I. (1990) · Neuropharmacology · doi:10.1016/0028-3908(90)90103-x · Cited by 23 · see citing works
Effects of Zoxazolamine and Related Centrally Acting Muscle Relaxants on Nigrostriatal Dopaminergic Neurons
Matthews, R. T., McMillen, B. A., Speciale, S. G., Jarrah, H. S., Shore, P. A., Sanghera, M. K., Shepard, D. S., & German, D. C. (1984) · Brain Research Bulletin · doi:10.1016/0361-9230(84)90163-1 · Cited by 23 · see citing works
Self-citation
The effect of amperozide on uptake and release of [3H]‐dopamine in vitro from perfused rat striatal and limbic brain areas
Eriksson, E., & Christensson, E. (1990) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1990.tb01606.x · Cited by 23 · see citing works
Inhibition of Brain Type A Monoamine Oxidase and 5‐Hydroxytryptamine Uptake by Two Amphetamine Metabolites, p‐Hydroxyamphetamine and p‐Hydroxynorephedrine
Arai, Y., Kim, S. K., Kinemuchi, H., Tadano, T., Satoh, S., Satoh, N., & Kisara, K. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04151.x · Cited by 22 · see citing works
Amphetamine, but not reserpine, protects mice against dopaminergic neurotoxicity of MPTP
Melamed, E., Rosenthal, J., COHEN, O., Uzzan, A., & Globus, M. (1985) · Neuropharmacology · doi:10.1016/0028-3908(85)90047-4 · Cited by 22 · see citing works
Tyramine‐induced noradrenaline release from rat brain slices: prevention by (‐)‐deprenyl
Glover, V. A. S., PYCOCK, C. J., & Sandler, M. (1983) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1983.tb11059.x · Cited by 21 · see citing works
Endogenous Dopamine (Da) Modulates [3H]spiperone Binding in Vivo in Rat Brain
Bischoff, S. F., Krauss, J., Grunenwald, C., Gunst, F., Heinrich, M., Schaub, M., Stöcklin, K., Vassout, A., Waldmeier, P. C., & Maître, L. (1991) · Journal of Receptor Research · doi:10.3109/10799899109066397 · Cited by 21 · see citing works
A simple method for screening Monoamine Oxidase (MAO) inhibitory drugs for type preference
Dorris, R. L. (1982) · Journal of Pharmacological Methods · doi:10.1016/0160-5402(82)90025-0 · Cited by 20 · see citing works
Pargyline increases 6-hydroxydopamine levels in the neostriatum of methamphetamine-treated rats
Marek, G. J., Vosmer, G. L., & Seiden, L. S. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90147-a · Cited by 20 · see citing works
Methamphetamine-elicited alterations of dopamine- and serotonin-metabolite levels within μ-opioid receptor knockout mice: a microdialysis study
Lan, K., Ma, T., Lin‐Shiau, S., Liu, S., & Ho, I.-K. (2007) · Journal of Biomedical Science · doi:10.1007/s11373-007-9218-7 · Cited by 18 · see citing works
“to DOPAC and/or inhibition of intra-neuronal MAO activity [37].”
Background
Effects of d-Methamphetamine on Monkey Brain Monoamine Oxidase, In Vivo and In Vitro
Egashira, T., Yamamoto, T., & Yamanaka, Y. (1987) · The Japanese Journal of Pharmacology · doi:10.1016/s0021-5198(19)43433-1 · Cited by 18 · see citing works
Methamphetamine Reward in Mice as Assessed by Conditioned Place Preference Test with Supermex® Sensors: Effect of Subchronic Clorgyline Pretreatment
Kitanaka, N., Kitanaka, J., Tatsuta, T., Watabe, K., Morita, Y., & Takemura, M. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9081-3 · Cited by 18 · see citing works
Effect of nicotine and amphetamine on the neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice
Sershen, H. W., Mason, M. F., Reith, M. E. A., Hashim, A. T., & Lajtha, Á. (1986) · Neuropharmacology · doi:10.1016/0028-3908(86)90140-1 · Cited by 17 · see citing works
Animal Models of Amphetamine Psychosis: Neurotransmitter Release from Rat Brain Slices
Lillrank, S. M., Oja, S. S., Saransaari, P., & Seppälä, T. T. (1991) · International Journal of Neuroscience · doi:10.3109/00207459109082032 · Cited by 17 · see citing works
Voltammetric Detection of Dopamine Release in the Rat Corpus Striatuma
Wightman, R. M., Kuhr, W. G., & Ewing, A. G. (1986) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1986.tb23607.x · Cited by 16 · see citing works
Midbrain Dopamine Neurons Defined by TrpV1 Modulate Psychomotor Behavior
Serra, G. P., Guillaumin, A., Dumas, S., Vlcek, B., & Wallén‐Mackenzie, Å. (2021) · Frontiers in Neural Circuits · doi:10.3389/fncir.2021.726893 · Cited by 15 · see citing works
“…locomotion is primarily based on cKO studies of the GLU aspect of the DA-GLU phenotype, either via cKO of the Vglut2 gene (Birgner et al., 2010; Hnasko et al., 2010; Fortin et al., 2012) or the glutamate recycling enzyme glutaminase (gene Gls1) (Mingote et al., 2017) in DA neurons.”
Background
Inhibition of monoamine oxidase (MAO) by α-ethylphenethylamine and N,α-diethylphenethylamine, two compounds related to dietary supplements
Santillo, M. F. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2014.10.009 · Cited by 15 · see citing works
Modification of Monoaminergic Activity by MAO Inhibitors Influences Methamphetamine Actions
Kitanaka, J., Kitanaka, N., & Takemura, M. (2006) · Drug Target Insights · doi:10.1177/117739280600100001 · Cited by 15 · see citing works
“1993), while the inhibition is weak compared with the actions of synthetic MAO inhibitors (Mantle et al. 1976; Miller et al. 1980).”
Background
3,4‐Methylenedioxymethamphetamine counteracts akinesia enantioselectively in rat rotational behavior and catalepsy
Lebsanft, H. B., Kohles, T., Kovar, K., & Schmidt, W. (2004) · Synapse · doi:10.1002/syn.20102 · Cited by 15 · see citing works
Stereospecific long-term effects of amphetamine on striatal dopamine neurons in rats
Steranka, L. R. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90119-9 · Cited by 15 · see citing works
Inhibition potential of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites on the in vitro monoamine oxidase (MAO)-catalyzed deamination of the neurotransmitters serotonin and dopamine
Steuer, A. E., Boxler, M. I., Stock, L., & Kræmer, T. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.12.001 · Cited by 14 · see citing works
Neurochemical effects of an acute treatment with 4-methylaminorex: a new stimulant of abuse
Bunker, C. F., Johnson, M., Gibb, J. W., Bush, L. G., & Hanson, G. R. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90597-y · Cited by 14 · see citing works
Suppressive effects of trihexyphenidyl on methamphetamine‐induced dopamine release as measured by in vivo microdialysis
Shimosato, K., Nagao, N., Watanabe, S., & Kitayama, S. (2003) · Synapse · doi:10.1002/syn.10191 · Cited by 14 · see citing works
“However, based on the fact that amphetamine inhibits MAO only at high doses (2–20 mg/ kg) (Miller et al., 1980), it is unlikely that the MAO inhibition accounts for the decrease in DOPAC level following the low dose (1 mg/kg) of MAP in the present study.”
Background
Involvement of intraterminal dopamine compartments in the amine release in the cat striatum
Leviel, V., & Guibert, B. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90715-4 · Cited by 14 · see citing works
Amphetamine and the Smart Drug 3,4-Methylenedioxypyrovalerone (MDPV) Induce Generalization of Fear Memory in Rats
Colucci, P., Mancini, G. F., Santori, A., Zwergel, C., Mai, A., Trezza, V., Roozendaal, B., & Campolongo, P. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00292 · Cited by 13 · see citing works
Modification of Monoaminergic Activity by MAO Inhibitors Influences Methamphetamine Actions.
Kitanaka, J., Kitanaka, N., & Takemura, M. (2006) · Europe PMC (PubMed Central) · Cited by 13 · see citing works
[3H]dopamine release by d-amphetamine from striatal synaptosomes of reserpinized rats
Masuoka, D. T., Alcaraz, A. F., & Schott, H. F. (1982) · Biochemical Pharmacology · doi:10.1016/0006-2952(82)90406-3 · Cited by 13 · see citing works
Low-dose pretreatment with clorgyline decreases the levels of 3-methoxy-4-hydroxyphenylglycol in the striatum and nucleus accumbens and attenuates methamphetamine-induced conditioned place preference in rats
Kitanaka, N., Kitanaka, J., Watabe, K., & Takemura, M. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.11.058 · Cited by 12 · see citing works
Rotational behaviour and neurochemical changes in unilateral N-methyl-norsalsolinol and 6-hydroxydopamine lesioned rats
Moser, A., Siebecker, F., Nobbe, F. A., & B�hme, V. (1996) · Experimental Brain Research · doi:10.1007/bf00227181 · Cited by 12 · see citing works
“S(+)-amphetamine is reported to have at least five distinct mechanisms of action (Iravani and Kruk 1995): release of dopamine through carrier-mediated diffusion via reversal of the dopamine uptake system (Connor and Kuczenski 1986), inhibition of dopamine reuptake (Jacocks and Cox 1992), inhibition of MAO (Miller et a…”
Background
Kava decreases the stereotyped behavior induced by amphetamine in mice
Krum, B. N., de Freitas, C. M., Ceretta, A. P. C., Barbosa, C. P., Reis, E. D. M., Scussel, R., Córneo, E. D. S., Machado‐de‐Ávila, R. A., Boligon, A. A., & Fachinetto, R. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113293 · Cited by 11 · see citing works
Chronic d-amphetamine depresses an imaging marker of arachidonic acid metabolism in rat brain
Bhattacharjee, A. K., Chang, L., Chen, M., White, L., Bell, J. M., Bazinet, R. P., & Rapoport, S. I. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708008833 · Cited by 10 · see citing works
“, 1980), by stimulating DA synthesis (Uretsky and Snodgrass, 1977), and by inhibiting brain monoamine oxidase activity (Miller et al., 1980).”
Background
Amphetamines and Derivatives
Albertson, T. E., Kenyon, N. J., & Morrissey, B. (2007) · Elsevier eBooks · doi:10.1016/b978-0-7216-0693-4.50049-9 · Cited by 10 · see citing works
The effects of a single dose of amphetamine and iprindole on the serotonergic system of the rat brain
Warren, P. F. (1984) · Neuropharmacology · doi:10.1016/0028-3908(84)90115-1 · Cited by 10 · see citing works
Inhibition of monoamine oxidase by two substrate-analogues, with different preferences for 5-hydroxytryptamine neurons
Kim, S. K., Toyoshima, Y., Arai, Y., Kinemuchi, H., Tadano, T., Oyama, K., Satoh, N., & Kisara, K. (1991) · Neuropharmacology · doi:10.1016/0028-3908(91)90057-i · Cited by 9 · see citing works
4-Phenyltetrahydroisoquinoline, but not nomifensine or cocaine, inhibits methamphetamine-induced dopamine release
Tateyama, M., Nagao, T., Ohta, S., Hirobe, M., & Hideki, O. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90544-r · Cited by 9 · see citing works
Simultaneous radioenzymatic assay of dopamine and dihydroxyphenylacetic acid: An index of in vivo dopamine release
Chengand, C. H., & Wooten, G. F. (1981) · Journal of Pharmacological Methods · doi:10.1016/0160-5402(81)90008-5 · Cited by 9 · see citing works
Selective inhibition of MAO-A in serotonergic synaptosomes by two amphetamine metabolites, p-hydroxyamphetamine and p-hydroxynorephedrine
Arai, Y., KyungKim, S., Kinemuchi, H., Tadano, T., Satoh, S., Satoh, N., Oyama, K., & Kisara, K. (1990) · Neurochemistry International · doi:10.1016/0197-0186(90)90046-v · Cited by 9 · see citing works
Comparative pharmacology and abuse potential of oral dexamphetamine and lisdexamfetamine—A literature review
Kämmerer, W. (2024) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2910 · Cited by 9 · see citing works
“In addition, dexamphetamine inhibits monoamine oxidase, resulting in a reduced breakdown of cytosolic monoamines (Miller et al., 1980).”
Attention-Deficit Hyperactivity Disorder (ADHD): A Comprehensive Overview of the Mechanistic Insights from Human Studies to Animal Models
Yacoub, M., Smith, S., Abbas, B., Iqbal, F., Jazieh, C., Shaer, N. S. H. A., Luk, C., & Syed, N. I. (2025) · Cells · doi:10.3390/cells14171367 · Cited by 12 · see citing works
“Concurrently, AMPH also impairs monoamine oxidase (MAO), preventing the breakdown of monoamines [213,214].”
On the role of monoamine oxidase-A for the maintenance of the volitional consumption of ethanol in two different rat models
Mega, B. T., Sheppard, K. W., Williams, H., & McMillen, B. A. (2002) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-002-0616-0 · Cited by 8 · see citing works
Synthesis of α- and β-methyl derivatives of 2-[(5-methoxy-1-methyl)indol-2-yl]ethylamine as selective inhibitors of monoamine oxidases A and B.
García, C. F., Marco, J. L., & Alvarez, E. F. (1992) · Tetrahedron · doi:10.1016/s0040-4020(01)89882-3 · Cited by 8 · see citing works
Effects of antipsychotic drugs on the long-term effects of amphetamine on nigro-striatal dopamine neurons in iprindole-treated rats
Steranka, L. R. (1984) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00495943 · Cited by 8 · see citing works
“The inhibition of type A monoamine oxidase by amphetamine (Miller et al. 1980) is viewed as an important contributing factor since DA released intraneuronally after amphetamine administration would then be protected from enzymatic destruction, which would be expected to increase the extent of DA auto-oxidation.”
Background
Computational modeling of extracellular dopamine kinetics suggests low probability of neurotransmitter release
Rooney, K. E., & Wallace, L. J. (2015) · Synapse · doi:10.1002/syn.21845 · Cited by 7 · see citing works
Revisiting the Role of Serotonin in Attention-Deficit Hyperactivity Disorder: New Insights from Preclinical and Clinical Studies
Solomon, M. B., Yegla, B., Newcorn, J. H., Maletic, V., Rubin, J. S., & Robbins, T. W. (2025) · Clinical Drug Investigation · doi:10.1007/s40261-025-01473-4 · Cited by 8 · see citing works
“In addition, amphetamine inhibits monoamine oxidase [237, 238].”

In vitro inhibition of monoamine oxidase types A and B by d- and l-amphetamine.
Hh, M., & De, C. (1978) · PubMed · Cited by 2 · see citing works
Effects of d-Methamphetamine on Monkey Brain Monoamine Oxidase, In Vivo and In Vitro
Egashira, T., Yamamoto, T., & Yamanaka, Y. (1987) · The Japanese Journal of Pharmacology · doi:10.1016/s0021-5198(19)43433-1 · Cited by 18 · see citing works
Effects of acute and repeated administration of amiflamine on mono amine oxidase inhibition in the rat
Ask, A., Fagervall, I., Jonze, M., Kelder, D., Nygren, R., & Ross, S. B. (1984) · Biochemical Pharmacology · doi:10.1016/0006-2952(84)90205-3 · Cited by 12 · see citing works
Some behavioral effects of P-fluordeprenyl enantiomers is rats
Tı́már, J., Gyarmati, S., BARNA, L., & Knoll, B. (1995) · Pharmacological Research · doi:10.1016/1043-6618(95)87372-4
Selective inhibition of monoamine oxidase in monoaminergic neurons in the rat brain
Ask, A., Fagervall, I., & Ross, S. B. (1983) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00497011 · Cited by 55 · see citing works

Authors: Miller, H. H., Shore, P. A., & Clarke, D. E.
Affiliations: University of Houston (US)
University of Texas Health Science Center at Dallas (US)
Corresponding author: Clarke, David E.
ORCID: Clarke, David E.
Venue: Biochemical Pharmacology
Publisher: Elsevier BV
Published: 1980-05
Volume: 29
Issue: 10
Pages: 1347-1354
ISSN: 0006-2952 (ISSN-L)
DOI: 10.1016/0006-2952(80)90429-3
OpenAlex: W2032273250
Cited by: 120
References: 32
Citations by year: 2026: 1 · 2025: 3 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 2 · 2017: 1 · 2016: 1 · 2015: 4 · 2014: 3 · 2013: 2
FWCI: 2.44
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Biochemical Pharmacology (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: d-amphetamine, L-amphetamine, monoamine oxidase inhibition, monoamine oxidase A, monoamine oxidase B, phenelzine, dopamine depletion, reserpine, cocaine, striatum
MeSH terms: Amphetamine, Animals, Brain, Cocaine, Corpus Striatum, Dextroamphetamine, Haloperidol, Male, Monoamine Oxidase Inhibitors, Phenelzine, 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-, 3,4-Dihydroxyphenylacetic Acid, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

In vivo monoamine oxidase inhibition by d-amphetamine

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cites

Cited by

Related

Record

About these checks